Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer
Clinical trial NCT03424473 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03424473
- Sponsor
- Seagen Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.